DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Neogen Chemicals Publishes Q1 FY27 Earnings Presentation for Investors

TipRanks 4 hrs ago·26 Jul 2026, 2:09 pm

Neogen Chemicals

Neogen Chemicals has released its earnings presentation for the first quarter of fiscal year 2027. This document provides investors with a detailed overview of the company's financial performance and strategic outlook for the upcoming period.

For shareholders, this update is crucial as it offers transparency into the company's operational health. By reviewing the presentation, investors can better understand the current market dynamics and how Neogen Chemicals plans to navigate them in the near future.

Investors should pay close attention to the management's commentary on key growth drivers and any guidance provided for the rest of the fiscal year. This information will be vital in assessing the company's trajectory and making informed investment decisions.